100% Quality Guarantee
PhD-Level Technical Support
Key Features

Monalizumab Biosimilar (NKG2A) Antibody (HDBS0085)

Datasheet
SKU HDBS0085
Antibody Type Biosimilar Reference Antibody
Applications IHC
Applications FC
Applications Drug Development
Applications Pharmacokinetics
Disease Area Cancer
Protein NKG2A
Reactivity Human
Host Species Chimeric Humanized
Isotype IgG4
$569

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.
Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries
Contact Sales Quote or discount
Find Distributor 50+ countries
Technical Support PhD-level team
Live Chat Available now

Description

system_update_altDatasheet

Monalizumab Biosimilar (NKG2A) Antibody (HDBS0085)

The Monalizumab Biosimilar NKG2A Antibody is a revolutionary product designed for research purposes related to NKG2A, a cell surface receptor known to regulate immune responses. This antibody, derived from innovative biosimilar technology, is highly specific and reactive with human samples, making it an invaluable tool for studies in immunology and cancer research.Through binding to the NKG2A protein, this antibody enables precise detection and analysis in various cell types, allowing researchers to gain insights into the role of NKG2A in immune regulation and its potential therapeutic implications.

With its ability to modulate immune responses, NKG2A has emerged as a promising target for investigating diseases such as cancer, autoimmune disorders, and viral infections.By utilizing the Monalizumab Biosimilar Anti-NKG2A Antibody in their research, scientists can advance their understanding of immune regulation mechanisms and explore new therapeutic strategies for addressing complex diseases. This cutting-edge product offers a novel approach to studying NKG2A and holds great potential for driving breakthroughs in the field of immunotherapy.

Product Name:Monalizumab Biosimilar (NKG2A) Antibody (HDBS0085)
Size:100 ug
Product SKU:HDBS0085
Target:NKG2A
Host Species:Humanized
Reactivity:Human
Recommended Dilution:Flow Cyt 1:100
Antibody Type:Monoclonal
Buffer:Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:IPH-2201, IPH2201, NN-8765, NNC-0141-0000-0100, NNC-141-01000, anti-NKG2A, humZ270
Buffer:Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:Powder
ApplicationsFlow Cyt
Antibody Isotype:IgG4
Guarantee:12 months from date of dispatch
Background:Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
Synonyms:CD159A, NKG2, NKG2A
Uniprot:P26715
View AllClose

0 Reviews

Write a Review
0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose

Related Products